Serum selenium is low in newly diagnosed Graves' disease: a population-based study
Serum selenium is low in newly diagnosed Graves' disease: a population-based study
复制标题
DOI:
10.1111/cen.12185
复制
发表时间:
2013-10-01
影响因子:
3.2
通讯作者:
Laurberg, Peter
中科院分区:
文献类型:
--
作者:
Pedersen, Inge Bulow;Knudsen, Nils;Laurberg, Peter
Context Selenium deficiency may play an important role in the initiation and progression of autoimmune thyroid disease.Objective To compare serum selenium (s-Se) values in patients with newly diagnosed autoimmune thyroid disease and controls from the Danish population.Design and settings S-Se was measured in triplicate by a fluorimetric method.Participants Patients with newly diagnosed Graves' disease (GD) (n=97) or autoimmune overt hypothyroidism (AIH) (n=96), euthyroid subjects with high serum levels of thyroid peroxidase antibody (TPO-Ab) (TPO-Ab > 1500U/ml, n=92) and random controls (n=830).Main outcome measure Differences in s-Se values.Results S-Se was lower in patients with GD than in controls (mean (SD), GD: 89.9g/l (18.4); controls: 98.8g/l (19.7), P < 0.01). This was confirmed in a multivariate logistic regression model adjusting for age, sex, mineral supplements, smoking, geographical region and time of sampling (P < 0.01). In a linear model, s-Se was similar in patients with AIH (mean (SD): 98.4g/l (24.9)) and in controls (P = 0.86). In the multivariate model however, s-Se was marginally lower in patients with AIH compared to controls (P = 0.04). There was no significant difference in s-Se between euthyroid participants with high TPO-Ab and random controls (linear: P = 0.97; multivariate: P = 0.27).Conclusion Patients with newly diagnosed GD and AIH had significantly lower s-Se compared with random controls. Our observation supports the postulated link between inadequate selenium supply and overt autoimmune thyroid disease, especially GD.